See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI98.74▲ 1.64%
← 0OI0 page
XStocksXray
Market X-Ray report · 21 October 2026

Archos S.A (0OI0)

London Exchange · UK · prices in EUR · close of 21 Oct 2026

Key indicators

Last closeEUR 0.255
52-week range0.164 – 0.447
Return, 1 month / 3 months−4.0% / +34.6%
Return, 1 year / 3 years+15.9% / –
TrendAbove 200-day, below 50-day
RSI (14)46
Volatility (1 year)59.2%
Worst drawdown (1 year)-36.8%
Average daily value traded0.00M EUR
Dividend yield–

Market X-Ray price-based

53/ 100 · Medium confidence · ahead of 50% of stocks on this exchange
Trend70
Momentum90
Stability (higher is calmer)28
Liquidity5
Income–

Five-year price chart navy: price · brown: 200-day average

-1.867.0215.9124.7933.672023-022025-022025-082026-032026-10

About the company

Archos is a French consumer electronics company based in Igny, near Paris. It designs and markets portable media players, tablet computers and related accessories, along with connected devices for home and mobile use. Its products are aimed at everyday consumers who want affordable gadgets for entertainment, computing and media playback. The company develops its own hardware designs and software, and its devices are offered through retail and online channels in Europe and other markets.

On this site Archos S.A appears as a stock on the London Exchange (UK), code 0OI0, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Archos S.A (0OI0) trades on the London Exchange in UK. It last closed at EUR 0.255 on 21 October 2026.

Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,880 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 15.9% and over the last three months it rose 34.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Archos S.A (0OI0)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend70 · FairMixed trend against its averages.
Above 200-day average19.4%
From 52-week high-33.6%
Momentum90 · StrongRising faster than most stocks on this exchange.
3-month return34.6%
6-month return27.5%
12-month return, skipping the last month–
Stability (higher is calmer)28 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)59.2%
Worst drawdown, 1 year (smaller is calmer)-36.8%
Liquidity5 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M EUR
Zero-volume days10.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−7.9%
1 month−4.0%
3 months+34.6%
6 months+27.5%
1 year+15.9%
3 years–
5 years–

Signals

50-day / 200-day average0.271 / 0.214
Golden / death cross (60 days)Golden, 39 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.011

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyNeutral5 bullish · 1 neutral · 4 bearish
MonthlyStrongly bullish5 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026